Cargando…

The clinical and pathological characteristics of IgA nephropathy patients in Tibet

BACKGROUND: There are few studies on immunoglobulin A nephropathy (IgAN) at high altitude. This study aimed to analyze the clinical and pathological characteristics of IgAN between Tibet and Beijing, which provided a basis for improving diagnosis and treatment in Tibet. METHOD: The clinical and path...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Fenglei, Mei, Jiarong, A, Yong, Tang, Chen, Yao, Yuxuan, Liu, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327142/
https://www.ncbi.nlm.nih.gov/pubmed/35896958
http://dx.doi.org/10.1186/s12882-022-02895-4
_version_ 1784757443416293376
author Si, Fenglei
Mei, Jiarong
A, Yong
Tang, Chen
Yao, Yuxuan
Liu, Lijun
author_facet Si, Fenglei
Mei, Jiarong
A, Yong
Tang, Chen
Yao, Yuxuan
Liu, Lijun
author_sort Si, Fenglei
collection PubMed
description BACKGROUND: There are few studies on immunoglobulin A nephropathy (IgAN) at high altitude. This study aimed to analyze the clinical and pathological characteristics of IgAN between Tibet and Beijing, which provided a basis for improving diagnosis and treatment in Tibet. METHOD: The clinical and pathological data of 80 patients from the People’s Hospital of Tibet Autonomous Region (Tibetan group) and 991 patients from Peking University First Hospital (Beijing group) with IgAN proven by renal biopsy were compared retrospectively between January 2016 and July 2020. The kidney biopsy tissue was sent to the Department of Nephrology, Peking University First Hospital for pathological evaluation. RESULTS: The proteinuria (2.9 [2.0, 4.9] vs. 1.1 [0.5, 2.4] g/day, P < 0.001) in the Tibetan group was significantly higher than that in the Beijing group. The serum albumin (30.4 ± 7.7 vs. 38.2 ± 5.5 g/L, P < 0.001) was significantly lower in the Tibetan group. The eGFR (77.7 ± 37.8 vs. 62.1 ± 33.6 ml/min/1.73 m(2), P = 0.001) was higher in the Tibetan group. The percentage of patients with nephrotic syndrome in the Tibetan group was significantly higher than that in the Beijing group (33.8% vs. 4.7%, P < 0.001). CONCLUSION: There are differences in the clinical and pathological characteristics of IgAN between plateau and plain regions.
format Online
Article
Text
id pubmed-9327142
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93271422022-07-28 The clinical and pathological characteristics of IgA nephropathy patients in Tibet Si, Fenglei Mei, Jiarong A, Yong Tang, Chen Yao, Yuxuan Liu, Lijun BMC Nephrol Research BACKGROUND: There are few studies on immunoglobulin A nephropathy (IgAN) at high altitude. This study aimed to analyze the clinical and pathological characteristics of IgAN between Tibet and Beijing, which provided a basis for improving diagnosis and treatment in Tibet. METHOD: The clinical and pathological data of 80 patients from the People’s Hospital of Tibet Autonomous Region (Tibetan group) and 991 patients from Peking University First Hospital (Beijing group) with IgAN proven by renal biopsy were compared retrospectively between January 2016 and July 2020. The kidney biopsy tissue was sent to the Department of Nephrology, Peking University First Hospital for pathological evaluation. RESULTS: The proteinuria (2.9 [2.0, 4.9] vs. 1.1 [0.5, 2.4] g/day, P < 0.001) in the Tibetan group was significantly higher than that in the Beijing group. The serum albumin (30.4 ± 7.7 vs. 38.2 ± 5.5 g/L, P < 0.001) was significantly lower in the Tibetan group. The eGFR (77.7 ± 37.8 vs. 62.1 ± 33.6 ml/min/1.73 m(2), P = 0.001) was higher in the Tibetan group. The percentage of patients with nephrotic syndrome in the Tibetan group was significantly higher than that in the Beijing group (33.8% vs. 4.7%, P < 0.001). CONCLUSION: There are differences in the clinical and pathological characteristics of IgAN between plateau and plain regions. BioMed Central 2022-07-27 /pmc/articles/PMC9327142/ /pubmed/35896958 http://dx.doi.org/10.1186/s12882-022-02895-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Si, Fenglei
Mei, Jiarong
A, Yong
Tang, Chen
Yao, Yuxuan
Liu, Lijun
The clinical and pathological characteristics of IgA nephropathy patients in Tibet
title The clinical and pathological characteristics of IgA nephropathy patients in Tibet
title_full The clinical and pathological characteristics of IgA nephropathy patients in Tibet
title_fullStr The clinical and pathological characteristics of IgA nephropathy patients in Tibet
title_full_unstemmed The clinical and pathological characteristics of IgA nephropathy patients in Tibet
title_short The clinical and pathological characteristics of IgA nephropathy patients in Tibet
title_sort clinical and pathological characteristics of iga nephropathy patients in tibet
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327142/
https://www.ncbi.nlm.nih.gov/pubmed/35896958
http://dx.doi.org/10.1186/s12882-022-02895-4
work_keys_str_mv AT sifenglei theclinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT meijiarong theclinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT ayong theclinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT tangchen theclinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT yaoyuxuan theclinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT liulijun theclinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT sifenglei clinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT meijiarong clinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT ayong clinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT tangchen clinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT yaoyuxuan clinicalandpathologicalcharacteristicsofiganephropathypatientsintibet
AT liulijun clinicalandpathologicalcharacteristicsofiganephropathypatientsintibet